October 1, 2021
Via: medicaldevice-network.comQIAGEN has secured a new contract from the US Government to boost production capacity for Covid-19 tests running on NeuMoDx instruments. The $3.4m contract was awarded by the Department of Defense (DoD). Under the contract, QIAGEN will increase production of […]
June 12, 2017
Via: medicaldevice-network.comMolecular diagnostics firm Qiagen has received the US Food and Drug Administration (FDA) approval for its fourth-generation blood test developed to detect latent tuberculosis (TB) infection. The new QuantiFERON-TB Gold Plus (QFT-Plus) test features CD8+ technology, which is expected to […]